Related Experiment Video
Updated: Jun 27, 2025

In Vitro Analysis of E3 Ubiquitin Ligase Function
Published on: May 14, 2021
Structural insights into the functional mechanism of the ubiquitin ligase E6AP
Zhen Wang1, Fengying Fan1,2, Zhihai Li2,3
1State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
Abstract:
E6AP dysfunction is associated with Angelman syndrome and Autism spectrum disorder. Additionally, the host E6AP is hijacked by the high-risk HPV E6 to aberrantly ubiquitinate the tumor suppressor p53, which is linked with development of multiple types of cancer, including most cervical cancers. Here we show that E6AP and the E6AP/E6 complex exist, respectively, as a monomer and a dimer of the E6AP/E6 protomer. The short α1-helix of E6AP transforms into a longer helical structure when in complex with E6. The extended α1-helices of the dimer intersect symmetrically and contribute to the dimerization. The two protomers sway around the crossed region of the two α1-helices to promote the attachment and detachment of substrates to the catalytic C-lobe of E6AP, thus facilitating ubiquitin transfer. These findings, complemented by mutagenesis analysis, suggest that the α1-helix, through conformational transformations, controls the transition between the inactive monomer and the active dimer of E6AP.
Insights
E3 ubiquitin ligase E6AP
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- E3 ubiquitin ligase E6AP dysfunction is implicated in Angelman syndrome and autism spectrum disorder.
- High-risk HPV E6 protein hijacks E6AP to ubiquitinate p53, contributing to various cancers, notably cervical cancer.
Purpose of the Study:
- To elucidate the structural mechanisms underlying E6AP activation and substrate ubiquitination.
- To investigate the role of the E6AP α1-helix in regulating E6AP's monomer-dimer transition.
Main Methods:
- X-ray crystallography to determine the structure of E6AP and the E6AP/E6 complex.
- Mutagenesis analysis to probe the function of the α1-helix.
Main Results:
- E6AP exists as an inactive monomer, while the E6AP/E6 complex forms an active dimer.
- Complexation with HPV E6 induces a conformational change in the E6AP α1-helix, promoting dimerization.
- The dimeric structure facilitates substrate binding and ubiquitin transfer through a swaying motion of protomers.
Conclusions:
- The E6AP α1-helix undergoes conformational changes that control its transition between inactive monomer and active dimer states.
- Structural insights into E6AP's activation mechanism provide a basis for understanding its role in disease and developing therapeutic strategies.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
The Proteasome Structure
The proteasome is an...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Anaphase Promoting Complex
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...

